Fig. 4.

ROC curve analyses using CPT1A to differentiate breast cancer from benign breast disease or healthy controls. a ROC curves of CPT1A for breast cancer patients versus healthy controls in the training set (left) and test set (right), respectively. b ROC curves of CPT1A for breast cancer patients versus benign breast cancer patients in the training set (left) and test set (right), respectively. c ROC curves of CPT1A for TNBC patients versus healthy controls in the training set (left) and test set (right), respectively